CompanyBiotechnology and Pharmaceuticals
BridgeBio
BridgeBio develops innovative medicines targeting genetic diseases, with a diverse pipeline addressing conditions like skin disorders, cancer, heart issues, and renal diseases.
genetic diseasesbiotechpharmaceuticalsclinical developmentrare diseases